To summarize, it can be said that an MSX1-expression can be found mainly in endometrioid endometrial carcinomas and is stronger stained in tumor material of patients with positive prognostic variables like a favorable T status or N status. This evidence concerns the gene MSX1 and endometrial endometrioid carcinoma.